Pecaut & Co. Novo Nordisk A S Transaction History
Pecaut & Co.
- $282 Million
- Q1 2025
A detailed history of Pecaut & Co. transactions in Novo Nordisk A S stock. As of the latest transaction made, Pecaut & Co. holds 21,587 shares of NVO stock, worth $1.51 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
21,587Holding current value
$1.51 Million% of portfolio
0.53%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.31 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.03 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$864 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$859 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$828 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $157B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...